Brian Hullinger, Chief Executive Officer and PresidentWhile traditional methods like urine and oral tests have a limited detection window, ranging from only 1-5 days; Psychemedics’ hair drug testing offers a remarkable 90-day window, providing a comprehensive view of an individual’s drug history. This extended window enables the identification of chronic or periodic drug use that might go undetected by other methods.
Brian Hullinger, Chief Executive Officer and President, explains, “Our testing method analyzes metabolites stored in hair, offering higher accuracy and reliability compared to traditional methods. This significantly reduces the chances of evasion or manipulation.”
Psychemedics’ approach is rooted in science, leveraging the fact that drugs’ active components are metabolized in the body and become part of the bloodstream. This process creates a historical record of drug use, with each segment of hair representing a timeline of drug exposure.
The company’s commitment to innovation is evident in its dedication to ongoing research and technological advancements. This ensures that its testing methods remain at the forefront of the industry, adapting to and encompassing emerging drug-use trends.
Most recently, Psychemedics helped an organization across multiple locations that faced challenges in maintaining a safe and drug-free workplace. Traditional drug testing methods, such as urine screening, proved inadequate in detecting the full spectrum of drug usage among their workforce. The implementation of Psychemedics’ hair drug testing program yielded remarkable results. The extended detection window helped identify previously undetected drug use patterns, leading to proactive intervention and a significant reduction in workplace accidents. With a clearer understanding of employee drug habits, the corporation saw a decrease in absenteeism and an uptick in productivity among tested departments. The comprehensive testing approach facilitated a cultural shift, promoting accountability and fostering a drug-free workplace environment.
Psychemedics’ recent change in leadership marks a pivotal moment for the company’s growth trajectory and research and development (R&D) initiatives, especially in advancing hair testing methodologies. The appointment of new leadership at Psychemedics underscores a strategic shift toward further innovation and expansion in hair testing. With a renewed vision and strategic direction, the company is poised to take forward its decades-long expertise while embracing new technologies, industries and methodologies.
Our testing method analyzes metabolites stored in hair, offering higher accuracy and reliability compared to traditional methods. This significantly reduces the chances of evasion or manipulation
The company is looking to channel resources and expertise into exploring new detection techniques, refining existing methodologies, and broadening the spectrum of detectable substances. The leadership change looks to herald a new era of industry standards in hair testing. Psychemedics’ dedication to R&D could lead to groundbreaking discoveries or improvements in testing accuracy, detection windows, and adaptability to emerging drug-use trends.
Psychemedics seeks to forge collaborations with research institutions, academic entities, and industry partners to foster innovation. These partnerships would accelerate the development of cutting-edge technologies and methodologies, strengthening Psychemedics’ position as a leader in hair drug testing.
